Catilusa, Florencia R.
HRN: 04-41-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
CEFTAZIDIME 1GM (VIAL)
10/09/2023
10/15/2023
IV
1gm
Q8
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes